Double-Blind NT-I7: Clinical Trials

1 trial of Double-Blind NT-I7, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Double-Blind NT-I7: new trials by email Literature Review of Double-Blind NT-I7 trials Research Report on Double-Blind NT-I7

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of NT-I7 in COVID-19 (SPESELPIS)
Double-Blind NT-I7, Double-Blind Placebo - COVID-19
Phase 1TerminatedNeoImmuneTech72020-11-272023-07-14

Conditions studied

COVID-19 (1)

Sponsors

NeoImmuneTech (1)

Countries

United States (1)